PURPOSE: We present the KAP levels and the determinants for diabetic retinopathy (DR)
screening and management at a private hospital in Riyadh, Saudi Arabia. METHODS: A …

Purpose To explore whether the prevalence and severity of retinopathy differ in diabetes
cohorts diagnosed through screening as compared with conventional health care. Methods …

Diabetic retinopathy (DR) is a global health burden. Screening for sight-threatening DR
(STDR) is the first cost-effective step to decrease this burden. We analyzed the similarities …

Background: The severity of diabetic retinopathy is well known to have a close association
with the duration of diabetes mellitus. Patients with recently diagnosed diabetes should have …

Introduction: Diabetic retinopathy (DR) is the commonest complication of diabetes mellitus
(DM), and is the leading cause of blindness among working adults. Modification of the …

Despite advances in screening for and treatment of diabetes, diabetic retinopathy and
maculopathy are still major causes of visual loss around the world. Systematic screening …

Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

Objective: To identify barriers to compliance with guidelines for diabetic retinopathy
screening. Methods: The population studied included 4410 adults, aged 31 to 64, enrolled in …

Background Diabetic retinopathy (DR) is a blinding yet treatable complication of diabetes.
DR screening is highly cost-effective at reducing blindness. Amidst the rapidly growing …

This guide is designed for policy-makers, public health leaders and senior clinicians
involved in planning, designing and implementing diabetic retinopathy screening …